[Regulation of chronic proliferative inflammation by anti-inflammatory drugs (author's transl)].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002351:Carrageenan; D003094:Collagen / Q000096:biosynthesis / Q000378:metabolism*; D004195:Disease Models, Animal; D006097:Granulation Tissue / Q000201:enzymology / Q000378:metabolism; D066298:In Vitro Techniques; D007249:Inflammation / Q000139:chemically induced / Q000378:metabolism*; D010396:Penicillamine / Q000494:pharmacology; D011393:Procollagen-Proline Dioxygenase / Q000378:metabolism; D051381:Rats
D000893:Anti-Inflammatory Agents; D002351:Carrageenan; D003094:Collagen; D011393:Procollagen-Proline Dioxygenase; D010396:Penicillamine